Impact of the CYP2C19*17 polymorphism on the pharmacokinetics and pharmacodynamics of proton pump inhibitors.
about
Impact of the CYP2C19*17 polymorphism on the pharmacokinetics and pharmacodynamics of proton pump inhibitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@en
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@nl
type
label
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@en
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@nl
prefLabel
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@en
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@nl
P2860
P356
P1476
Impact of the CYP2C19*17 polym ...... ics of proton pump inhibitors.
@en
P2093
John van den Anker
P2860
P356
10.1002/JCPH.18
P577
2013-02-04T00:00:00Z